Promea Therapeutics Profile
Key Indicators
- Authorised Capital ₹ 4.00 Cr
- Paid Up Capital ₹ 3.86 Cr
- Company Age 7 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 42.46 Cr
- Revenue Growth 98.06%
- Profit Growth -17198.90%
- Ebitda 225.23%
- Net Worth -28.66%
- Total Assets 24.16%
About Promea Therapeutics
Promea Therapeutics Private Limited (PTPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 31 July 2017 (Seven years and nine months 17 days old ). Its registered office is in Medak, Telangana, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 4.00 Cr and a paid-up capital of Rs 3.86 Cr.
The company currently has active open charges totaling ₹42.46 Cr.
Rajesh Tummuru and Pooja Gaddam serve as directors at the Company.
Company Details
- Location
Medak, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24304TG2017PTC118617
- Company No.
118617
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
31 Jul 2017
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Healthcare
What products or services does Promea Therapeutics Private Limited offer?
Promea Therapeutics Private Limited offers a wide range of products and services, including Medical Laboratory Instruments, Corona Test Kit.
Promea Therapeutics Private Limited
Explore comprehensive data for Promea Therapeutics Private Limited, including financials, compliance details, shareholding patterns, and litigation history.
Who are the key members and board of directors at Promea Therapeutics?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pooja Gaddam  | Director | 31-Jul-2017 | Current |
| Rajesh Tummuru | Director | 09-Oct-2017 | Current |
Financial Performance of Promea Therapeutics.
Promea Therapeutics Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 98.06% increase. The company also saw a substantial fall in profitability, with a 17198.9% decrease in profit. The company's net worth observed a substantial decline by a decrease of 28.66%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Promea Therapeutics?
Unlock access to Promea Therapeutics's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Promea Care Private LimitedRajesh Tummuru and Pooja Gaddam are mutual person
Previa Health Private LimitedRajesh Tummuru is a mutual person
Bionutra Private LimitedRajesh Tummuru is a mutual person
- Cytobiologics Private Limited
Rajesh Tummuru is a mutual person
- Biogenico Private Limited
Rajesh Tummuru is a mutual person
- Trait Health Private Limited
Rajesh Tummuru is a mutual person
Charges (Loans)
Open Charges
₹42.46 Cr
Satisfied Charges
₹0
Charges Breakdown by Lending Institutions
- Others : 40.71 Cr
- Axis Bank Limited : 1.75 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 01 Jul 2024 | Others | ₹21.75 Cr | Open |
| 29 Dec 2022 | Axis Bank Limited | ₹1.75 Cr | Open |
| 24 May 2021 | Others | ₹18.96 Cr | Open |
How Many Employees Work at Promea Therapeutics?
Promea Therapeutics has a workforce of 174 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Promea Therapeutics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Promea Therapeutics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Promea Therapeutics
Recent activity within the organization
- Annual General Meeting
Promea Therapeutics Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
- Charges
A charge with Others amounted to Rs. 21.75 Cr with Charge ID 100955463 was registered on 01 Jul 2024.
- Charges
A charge with Others of Rs. 18.96 Cr registered on 24 May 2021 with Charge ID 100470484 was modified on 01 Jul 2024.
- Balance Sheet
Promea Therapeutics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad.
- Charges
A charge with Axis Bank Limited amounted to Rs. 1.75 Cr with Charge ID 100695360 was registered on 29 Dec 2022.
- Charges
A charge with Others amounted to Rs. 18.96 Cr with Charge ID 100470484 was registered on 24 May 2021.
Frequently asked questions
What is the Incorporation or founding date of Promea Therapeutics Private Limited?
Promea Therapeutics Private Limited was incorporated on 31 Jul 2017.
What is authorized share capital and paid-up capital of Promea Therapeutics Private Limited?
The authorized share capital of Promea Therapeutics Private Limited is ₹ 4.00 Cr and paid-up capital is ₹ 3.86 Cr.
Who are the current board members & directors of Promea Therapeutics Private Limited?
Currently 2 directors are associated with Promea Therapeutics Private Limited.
- Rajesh Reddy Tummuru
- Pooja Aakanksha Gaddam
What is the registered address of Promea Therapeutics Private Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Promea Therapeutics Private Limited is Plot No. M4, Medical Device Park Sultanpur (V) India, Patancheru, Telangana, 502319.
What is the corporate identification number (CIN) and company number of Promea Therapeutics Private Limited?
The corporate identification number (CIN) of Promea Therapeutics Private Limited is U24304TG2017PTC118617 and the company number is 118617 as per Ministry of Corporate Affairs (MCA).
What is the official website of Promea Therapeutics Private Limited?
The Official website of Promea Therapeutics Private Limited is https://www.promea.in
What has been the recent revenue trend for Promea Therapeutics Private Limited?
According to the financial reports for the fiscal year 2023, the revenue trend for Promea Therapeutics Private Limited has risen by 98.06%.
How many employees does Promea Therapeutics Private Limited currently have?
As Per 2023 financial reports, 174 employees are currently employed by Promea Therapeutics Private Limited.
What change has been observed in the net worth of Promea Therapeutics Private Limited, and by what percentage?
The financial reports for the fiscal year 2023 indicates that The net worth of Promea Therapeutics Private Limited has experienced an downturn of -28.66%.
What are the total open charges for Promea Therapeutics Private Limited?
As per the financial statements for fiscal Year 2023, The total open charges for Promea Therapeutics Private Limited amount to ₹ 42.46 Cr.
When was the last Balance Sheet of Promea Therapeutics Private Limited filed with the ROC?
The most recent Balance Sheet for Promea Therapeutics Private Limited was filed with the ROC on 31 Mar 2024.
Unlock Business Insights – Explore Instantly!
Search company & director profiles for free and gain access to critical business data.
- 3.1M+ Companies
- 15M+ Legal Cases
- 525K+ Credit Ratings
- 5.8M+ Directors & KMP
- 750K+ Regulatory Alerts
- 1.1M+ Companies' Financial Records
People also Viewed
GR
Gaddam RanjithDirector
Similar Companies Based on Medical & Laboratory Equipment
Carl Zeiss India (Bangalore) Private Limited Bangaluru, Karnataka, India
Thermo Fisher Scientific India Private Limited Mumbai, Maharashtra, India
Siemens Healthcare Private Limited Mumbai, Maharashtra, India
Mindray Medical India Pvt. Ltd. Mumbai, Maharashtra, India
Wipro Ge Healthcare Private Limited Bangaluru, Karnataka, India
Poly Medicure Limited Delhi, India
Transasia Bio-Medicals Limited Mumbai, Maharashtra, India
Becton Dickinson India Private Limited. New Delhi, India